The Chinese herbal formulation Biminne in management of perennial allergic rhinitis: a randomized, double-blind, placebo-controlled, 12-week clinical trial

Authors: Hu, Guorang1; Walls, Ronald S.1; Bass, Diana2; Bullock, Ramon2; Grayson, Dave1; Jones, Mark3; Gebski, Val3

Source: Annals of Allergy, Asthma and Immunology, Volume 88, Number 5, May 2002 , pp. 478-487(10)

Publisher: American College of Allergy, Asthma, & Immunology

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Background: Herbal therapies have been widely used in allergic rhinitis (AR), but none have been shown to be effective in controlled scientific clinical trials.

Objective: The aim of this study was to test the effects of the Chinese herbal formulation Biminne in patients with moderate to severe perennial AR.

Methods: In a randomized, double-blind, placebo-controlled clinical trial, 58 patients were randomized to receive either Biminne capsules (n = 26) or placebo (n = 32) in doses of five capsules twice a day for 12 weeks. Main outcomes were measured by changes in symptom diaries, quality of life scores, patients' evaluations of improvement on visual analog scores, and physicians' overall evaluation. Total serum immunoglobulin E was measured in all patients without knowledge of which group they were in. After 1 year we performed a randomized, double-blind, dose-response study in 22 patients who had previously received placebo.

Results: The trial outcomes evaluated by four instruments showed a statistically significant improvement in some of the symptoms of AR, whereas others exhibited a positive trend that did not reach statistical significance. Followup 1 year after completion of the trial suggested that benefit of the treatment persisted. A pilot dose-response study showed both half and full strengths were effective. Total serum immunoglobulin E was reduced after the herbal treatment.

Conclusions: Our results suggest the Biminne formulation is effective in treatment of perennial AR. Its mode of action is unknown.

Document Type: Original article

Affiliations: 1: Department of Medicine, University of Sydney, Sydney, Australia. 2: Department of Immunology and Allergy, Concord Hospital, Sydney, Australia. 3: NHMRC Clinical Trials Center, Sydney, Australia.

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$28.00 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A